Akoya Biosciences Inc
NASDAQ:AKYA 1:35:13 PM EDT
| Market Cap (Intraday) | 187.71M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.93 |
| 50-Day MA | $4.79 |
| 200-Day MA | $4.89 |
Akoya Biosciences Inc Stock, NASDAQ:AKYA
100 Campus Drive, 6th Floor, Marlborough, Massachusetts 01752
United States of America
Phone: +1.855.896.8401
Number of Employees: 330
Description
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.